Archive: 09/12/2015
Health professionals lack knowledge about female genital mutilation
Health practitioners need more resources and expert guidelines to provide appropriate medical and psychological treatment for women and girls that have had female genital mutilation or cutting, says a new review of the evidence ...
Dec 9, 2015
Capecitabine improved outcomes for breast cancer patients with disease after presurgery chemo
Treatment with the chemotherapy agent capecitabine increased disease-free survival for women with HER2-negative breast cancer that was not eliminated by presurgery chemotherapy, according to results from the phase III CREATE-X ...
Dec 9, 2015
Pathologic complete response to presurgery chemo improves survival for patients with TNBC
Patients with stage 2 or stage 3 triple-negative breast cancer (TNBC) who had a pathologic complete response (pCR) after presurgery chemotherapy had increased event-free and overall survival compared with those who had more ...
Dec 9, 2015
Women with luminal A subtype of breast cancer did not benefit from adjuvant chemotherapy
Premenopausal women whose invasive breast cancers were of the luminal A subtype had comparable 10-year disease-free survival rates regardless of whether or not they received adjuvant chemotherapy, according to data from the ...
Dec 9, 2015
Denosumab improves disease-free survival for postmenopausal patients w HR+ breast cancer
Adding denosumab to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal patients with early-stage, hormone receptor (HR)-positive breast cancer, according to results from the phase III ABCSG-18 ...
Dec 9, 2015